<tei xml:space="preserve">
    <teiHeader>
        <fileDesc xml:id="_0"/>
    </teiHeader>
    <text xml:lang="en">
        <listBibl>

        REFERENCES<lb/> 
        <bibl><label>1</label>. Bloebaum R. Managing allergic rhinitis: the role of pharmacotherapy; sound treat-<lb/>ment can improve your patient&apos;s quality of life. J Respir Dis 2002;23:370-6.<lb/> </bibl>
        <bibl><label>2</label>. Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc 2007;28:3-9.<lb/> </bibl>
        <bibl><label>3</label>. Settipane RA. Rhinitis: a dose of epidemiological reality. Allergy Asthma Proc<lb/> 2003;24:147-54.<lb/> </bibl>
        <bibl><label>4</label>. Berger WE. Allergic rhinitis in children: diagnosis and management strategies.<lb/> Paediatr Drugs 2004;6:233-50.<lb/> </bibl>
        <bibl><label>5</label>. McCrory DC, Williams JW, Dolor RJ, Gray RN, Kolimaga JT, Reed S, et al.<lb/> Management of allergic rhinitis in the working-age population. Evid Rep Technol<lb/> Assess (Summ) 2003;(67):1-4.<lb/> </bibl>
        <bibl><label>6</label>. Wright AL, Holberg CJ, Martinez FD, Halonen M, Morgan W, Taussig LM. Epi-<lb/>demiology of physician-diagnosed allergic rhinitis in childhood. Pediatrics 1994;<lb/> 94:895-901.<lb/> </bibl>
        <bibl><label>7</label>. HealthStar Communications, Inc, in partnership with Schulman, Ronca and Bucu-<lb/>valas, Inc. Allergies in America: a landmark survey of nasal allergy sufferers.<lb/> Executive summary. Florham Park, NJ: Altana Pharma US, Inc; 2006.<lb/> </bibl>
        <bibl><label>8</label>. Meltzer E, Blaiss M, Derebery M, Boyle J, Naclerio R, Hadley J, et al. Perspectives<lb/> on allergic rhinitis and its treatment. Allergy Asthma Proc 2007;28(suppl):S1-32.<lb/> </bibl>
        <bibl><label>9</label>. Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection,<lb/> and diagnosis. J Allergy Clin Immunol 2001;108(suppl):S2-8.<lb/> </bibl>
        <bibl><label>10</label>. Dykewicz MS, Fineman S, Skoner DP, Nicklas R, Lee R, Blessing-Moore J, et al. Di-<lb/>agnosis and management of rhinitis: complete guidelines of the Joint Task Force on<lb/> Practice Parameters in Allergy, Asthma and Immunology. American Academy of Al-<lb/>lergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 1998;81:478-518.<lb/> </bibl>
        <bibl><label>11</label>. Trangsrud AJ, Whitaker AL, Small RE. Intranasal corticosteroids for allergic rhi-<lb/>nitis. Pharmacotherapy 2002;22:1458-67.<lb/> </bibl>
        <bibl><label>12</label>. Waddell AN, Patel SK, Toma AG, Maw AR. Intranasal steroid sprays in the treat-<lb/>ment of rhinitis: is one better than another? J Laryngol Otol 2003;117:843-5.<lb/> </bibl>
        <bibl><label>13</label>. Skoner DP, Gentile D, Angelini B, Kane R, Birdsall D, Banerji D. The effects of<lb/> intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-<lb/>term bone growth and HPA axis in children with allergic rhinitis. Ann Allergy<lb/> Asthma Immunol 2003;90:56-62.<lb/> </bibl>
        <bibl><label>14</label>. Skoner DP, Rachelefsky GS, Meltzer EO, Chervinsky P, Morris RM, Seltzer JM,<lb/> et al. Detection of growth suppression in children during treatment with intranasal<lb/> beclomethasone dipropionate. Pediatrics 2000;105:e23.<lb/> </bibl>
        <bibl><label>15</label>. Wihl JA, Andersson KE, Johansson SA. Systemic effects of two nasally adminis-<lb/>tered glucocorticosteroids. Allergy 1997;52:620-6.<lb/> </bibl>
        <bibl><label>16</label>. Wilson AM, McFarlane LC, Lipworth BJ. Effects of repeated once daily dosing of<lb/> three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pi-<lb/>tuitary-adrenal-axis activity. J Allergy Clin Immunol 1998;101:470-4.<lb/> </bibl>
        <bibl><label>17</label>. Spector SL. Overview of comorbid associations of allergic rhinitis. J Allergy Clin<lb/> Immunol 1997;99(suppl):S773-80.<lb/> </bibl>
        <bibl><label>18</label>. Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA,<lb/> et al. The diagnosis and management of rhinitis: an updated practice parameter.<lb/> J Allergy Clin Immunol 2008;122(suppl):S1-84.<lb/> </bibl>
        <bibl><label>19</label>. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on<lb/> asthma. J Allergy Clin Immunol 2001;108(suppl):S147-334.<lb/> </bibl>
        <bibl><label>20</label>. Douglass JA, O&apos;Hehir RE. 1. Diagnosis, treatment and prevention of allergic dis-<lb/>ease: the basics. Med J Aust 2006;185:228-33.<lb/> </bibl>
        <bibl><label>21</label>. Jeffery PK, Haahtela T. Allergic rhinitis and asthma: inflammation in a one-airway<lb/> condition. BMC Pulm Med 2006;6(suppl 1):S5.<lb/> </bibl>
        <bibl><label>22</label>. Lai L, Casale TB, Stokes J. Pediatric allergic rhinitis: treatment. Immunol Allergy<lb/> Clin North Am 2005;25:283-99, vi.<lb/> </bibl>
        <bibl><label>23</label>. Bielory L, Katelaris CH, Lightman S, Naclerio RM. Treating the ocular component<lb/> of allergic rhinoconjunctivitis and related eye disorders. MedGenMed 2007;9:35.<lb/> </bibl>
        <bibl><label>24</label>. Meltzer EO. Evaluation of the optimal oral antihistamine for patients with allergic<lb/> rhinitis. Mayo Clin Proc 2005;80:1170-6.<lb/> </bibl>
        <bibl><label>25</label>. Ogden CL, Carroll MD, Flegal KM. High body mass index for age among US chil-<lb/>dren and adolescents, 2003-2006. JAMA 2008;299:2401-5.<lb/> </bibl>
        <bibl><label>26</label>. Craig TJ, McCann JL, Gurevich F, Davies MJ. The correlation between allergic<lb/> rhinitis and sleep disturbance. J Allergy Clin Immunol 2004;114(suppl):S139-45.<lb/> </bibl>
        <bibl><label>27</label>. Young T, Finn L, Kim H. Nasal obstruction as a risk factor for sleep-disordered<lb/> breathing. The University of Wisconsin Sleep and Respiratory Research Group.<lb/> J Allergy Clin Immunol 1997;99(suppl):S757-62.<lb/> </bibl>
        <bibl><label>28</label>. Golbin A, Bernales R, Lim D. Perennial allergic rhinitis (PAR), and sleep disorders<lb/> [abstract]. </bibl>
<bibl>Ann Allergy 1992;68:85.<lb/> </bibl>
        <bibl><label>29</label>. Juniper E. Measurement of health-related quality of life: adult rhinoconjunctivitis.<lb/> 2005. Available at: http://qoltech.co.uk/Rhinocon.htm. Accessed May 6, 2008.<lb/> </bibl>
        <bibl><label>30</label>. Klossek JM, Gohler C, Vervloet D, Deslandes B, Dufour X, Neukirch F. [Epidemi-<lb/>ology of seasonal spring-time allergic rhinitis in adults in France]. Presse Med<lb/> 2005;34:348-52.<lb/> </bibl>
        <bibl><label>31</label>. Lavie P, Gertner R, Zomer J, Podoshin L. Breathing disorders in sleep associated<lb/> with &apos;&apos;microarousals&apos;&apos; in patients with allergic rhinitis. Acta Otolaryngol 1981;92:<lb/> 529-33.<lb/> </bibl>
        <bibl><label>32</label>. Spaeth J, Klimek L, Mosges R. Sedation in allergic rhinitis is caused by the con-<lb/>dition and not by antihistamine treatment. Allergy 1996;51:893-906.<lb/> </bibl>
        <bibl><label>33</label>. Stuck BA, Czajkowski J, Hagner AE, Klimek L, Verse T, Hormann K, et al. Changes<lb/> in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic<lb/> rhinitis: a controlled clinical trial. J Allergy Clin Immunol 2004;113:663-8.<lb/> </bibl>
        <bibl><label>34</label>. Gozal D. Sleep-disordered breathing and school performance in children. Pediat-<lb/>rics 1998;102:616-20.<lb/> </bibl>
        <bibl><label>35</label>. Owens J, Opipari L, Nobile C, Spirito A. Sleep and daytime behavior in children<lb/> with obstructive sleep apnea and behavioral sleep disorders. Pediatrics 1998;102:<lb/> 1178-84.<lb/> </bibl>
        <bibl><label>36</label>. Vuurman EF, van Veggel LM, Uiterwijk MM, Leutner D, O&apos;Hanlon JF. Seasonal<lb/> allergic rhinitis and antihistamine effects on children&apos;s learning. Ann Allergy<lb/> 1993;71:121-6.<lb/> </bibl>
        <bibl><label>37</label>. Bresolin D, Shapiro PA, Shapiro GG, Chapko MK, Dassel S. Mouth breathing in<lb/> allergic children: its relationship to dentofacial development. Am J Orthod 1983;<lb/> 83:334-40.<lb/> </bibl>
        <bibl><label>38</label>. Slavin RG. Complications of allergic rhinitis: implications for sinusitis and asthma.<lb/> J Allergy Clin Immunol 1998;101(suppl):S357-60.<lb/> </bibl>
        <bibl><label>39</label>. Bernstein JM, Lee J, Conboy K, Ellis E, Li P. Further observations on the role of<lb/> IgE-mediated hypersensitivity in recurrent otitis media with effusion. Otolaryngol<lb/> Head Neck Surg 1985;93:611-5.<lb/> </bibl>
        <bibl><label>40</label>. Tomonaga K, Kurono Y, Mogi G. The role of nasal allergy in otitis media with<lb/> effusion. A clinical study. Acta Otolaryngol Suppl 1988;458:41-7.<lb/> </bibl>
        <bibl><label>41</label>. Bernstein JM. The role of IgE-mediated hypersensitivity in the development of oti-<lb/>tis media with effusion. Otolaryngol Clin North Am 1992;25:197-211.<lb/> </bibl>
        <bibl><label>42</label>. Meltzer EO, Szwarcberg J, Pill MW. Allergic rhinitis, asthma, and rhinosinusitis:<lb/> diseases of the integrated airway. J Manag Care Pharm 2004;10:310-7.<lb/> </bibl>
        <bibl><label>43</label>. Nayak AS. The asthma and allergic rhinitis link. Allergy Asthma Proc 2003;24:<lb/> 395-402.<lb/> </bibl>
        <bibl><label>44</label>. Casale TB, Dykewicz MS. Clinical implications of the allergic rhinitis-asthma link.<lb/> Am J Med Sci 2004;327:127-38.<lb/> </bibl>
        <bibl><label>45</label>. Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. Quality of life in allergic<lb/> rhinitis and asthma. A population-based study of young adults. Am J Respir Crit<lb/> Care Med 2000;162:1391-6.<lb/> </bibl>
        <bibl><label>46</label>. Anderson HR, Pottier AC, Strachan DP. Asthma from birth to age 23: incidence<lb/> and relation to prior and concurrent atopic disease. Thorax 1992;47:537-42.<lb/> </bibl>
        <bibl><label>47</label>. Behbehani NA, Abal A, Syabbalo NC, Abd Azeem A, Shareef E, Al-Momen J.<lb/> Prevalence of asthma, allergic rhinitis, and eczema in 13-to 14-year-old children<lb/> in Kuwait: an ISAAC study. International Study of Asthma and Allergies in Child-<lb/>hood. Ann Allergy Asthma Immunol 2000;85:58-63.<lb/> </bibl>
        <bibl><label>48</label>. Kalyoncu AF, Selcuk ZT, Enunlu T, Demir AU, Coplu L, Sahin AA, et al. Preva-<lb/>lence of asthma and allergic diseases in primary school children in Ankara, Turkey:<lb/> two cross-sectional studies, five years apart. Pediatr Allergy Immunol 1999;10:<lb/> 261-5.<lb/> </bibl>
        <bibl><label>49</label>. Sears MR, Burrows B, Flannery EM, Herbison GP, Holdaway MD. Atopy in child-<lb/>hood. I. Gender and allergen related risks for development of hay fever and asthma.<lb/> Clin Exp Allergy 1993;23:941-8.<lb/> </bibl>
        <bibl><label>50</label>. Selnes A, Nystad W, Bolle R, Lund E. Diverging prevalence trends of atopic dis-<lb/>orders in Norwegian children. Results from three cross-sectional studies. Allergy<lb/> 2005;60:894-9.<lb/> </bibl>
        <bibl><label>51</label>. Werneck G, Ruiz S, Hart R, White M, Romieu I. Prevalence of asthma and other<lb/> childhood allergies in Brazilian schoolchildren. J Asthma 1999;36:677-90.<lb/> </bibl>
        <bibl><label>52</label>. Corren J, Adinoff AD, Buchmeier AD, Irvin CG. Nasal beclomethasone prevents<lb/> the seasonal increase in bronchial responsiveness in patients with allergic rhinitis<lb/> and asthma. J Allergy Clin Immunol 1992;90:250-6.<lb/> </bibl>
        <bibl><label>53</label>. Crystal-Peters J, Neslusan C, Crown WH, Torres A. Treating allergic rhinitis in pa-<lb/>tients with comorbid asthma: the risk of asthma-related hospitalizations and emer-<lb/>gency department visits. J Allergy Clin Immunol 2002;109:57-62.<lb/> </bibl>
        <bibl><label>54</label>. Foresi A, Pelucchi A, Gherson G, Mastropasqua B, Chiapparino A, Testi R. Once<lb/> daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms<lb/> and inflammation but also attenuates the increase in bronchial responsiveness dur-<lb/>ing the pollen season in allergic rhinitis. J Allergy Clin Immunol 1996;98:274-82.<lb/> </bibl>
        <bibl><label>55</label>. Watson WT, Becker AB, Simons FE. Treatment of allergic rhinitis with intranasal<lb/> corticosteroids in patients with mild asthma: effect on lower airway responsiveness.<lb/> J Allergy Clin Immunol 1993;91:97-101.<lb/> </bibl>
        <bibl><label>56</label>. Welsh PW, Stricker WE, Chu CP, Naessens JM, Reese ME, Reed CE, et al. Effi-<lb/>cacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving<lb/> symptoms of ragweed allergy. Mayo Clin Proc 1987;62:125-34.<lb/> </bibl>
        <bibl><label>57</label>. New survey suggests patients want fast, long relief of allergy symptoms. PRN<lb/> Newswire. March 20, 2006.<lb/> </bibl>
        <bibl><label>58</label>. Eggleston PA. Improving indoor environments: reducing allergen exposures. J Al-<lb/>lergy Clin Immunol 2005;116:122-6.<lb/> </bibl>
        <bibl><label>59</label>. Ferguson BJ. Environmental controls of allergies. Otolaryngol Clin North Am<lb/> 2008;41:411-7.<lb/> </bibl>
        <bibl><label>60</label>. Meltzer EO. Allergic rhinitis: managing the pediatric spectrum. Allergy Asthma<lb/> Proc 2006;27:2-8.<lb/> </bibl>
        <bibl><label>61</label>. Belliveau PP. Omalizumab: a monoclonal anti-IgE antibody. MedGenMed 2005;<lb/> 7:27.<lb/> </bibl>
        <bibl><label>62</label>. Bello CE, Garrett SD. Therapeutic issues in oral glucocorticoid use. Lippincotts<lb/> Prim Care Pract 1999;3:333-42.<lb/> </bibl>
        <bibl><label>63</label>. Naclerio R, Hadley J, Stoloff S, Nelson H. Patient and physician perspectives on the<lb/> attributes of nasal allergy medications. Allergy Asthma Proc 2007;28(suppl):S11-7.<lb/> </bibl>
        <bibl><label>64</label>. Blaiss MS. Important aspects in management of allergic rhinitis: compliance, cost,<lb/> and quality of life. Allergy Asthma Proc 2003;24:231-8.<lb/> </bibl>
        <bibl><label>65</label>. Cochrane GM. Compliance and outcomes in patients with asthma. Drugs 1996;<lb/> 52(suppl 6):12-9.<lb/> </bibl>
        <bibl><label>66</label>. Shusterman D, Murphy MA. Nasal hyperreactivity in allergic and non-allergic<lb/> rhinitis: a potential risk factor for non-specific building-related illness. Indoor<lb/> Air 2007;17:328-33.<lb/> </bibl>
        <bibl><label>67</label>. Settipane RA, Charnock DR. Epidemiology of rhinitis: allergic and nonallergic.<lb/> Clin Allergy Immunol 2007;19:23-34.<lb/> </bibl>
        <bibl><label>8</label>. How much need is there for education for people with nasal<lb/> allergies about their condition and its treatment? Do you<lb/> think there is a strong need or a moderate need?<lb/> HCPs<lb/> </bibl>
        <bibl><label>1</label>. Approximately what proportion of your patients 4 to 17<lb/> years of age with nasal allergies would you say are very sat-<lb/>isfied with the management of their disease?<lb/> </bibl>
        <bibl><label>2</label>. In general, how satisfied are your patients with AR 4 to 17 years<lb/> of age with their prescription nasal spray-very satisfied,<lb/> somewhat satisfied, somewhat dissatisfied, or very dissatisfied?<lb/> </bibl>
        <bibl><label>3</label>. What is your preferred choice of medication?<lb/> A. anticholinergic nasal spray<lb/> B. antihistamines (OTC)<lb/> </bibl>
<bibl>C. antihistamines (prescription)<lb/> D. antihistamine-decongestant combination (OTC)<lb/> </bibl>
<bibl>E. antihistamine-decongestant combination (prescription)<lb/> F. decongestant (OTC)<lb/> </bibl>
<bibl>G. inhaled corticosteroids<lb/> H. leukotriene inhibitors<lb/> I. mast cell stabilizers (cromolyn)<lb/> J. decongestant nasal sprays (OTC)<lb/> K. intranasal antihistamines/antihistamine nasal sprays<lb/> </bibl>
        <bibl><label>4</label>. Overall, do your patients 4 to 17 years of age believe they<lb/> get their money&apos;s worth out of prescription medicines for na-<lb/>sal allergies?<lb/> </bibl>
        <bibl><label>5</label>. How much need do you think there is for better education of<lb/> parents of children with nasal allergies about their condition<lb/> and its treatment-a strong need or a moderate need?</bibl>
        </listBibl>
    </text>
</tei>

